Navigation Links
BioMotiv Secures $21 million in Initial Funding
Date:9/5/2012

CLEVELAND, Sept. 5, 2012 /PRNewswire/ -- BioMotiv today announced that it has secured $21 million in financing from its founding investors, University Hospitals and the Harrington Family. 

"BioMotiv is a new model for accelerating breakthrough discoveries into medicines and aligning capital and collaborations to develop a portfolio of therapeutics," said Baiju R. Shah, Chief Executive Officer of BioMotiv.  "Through their commitment, University Hospitals and the Harrington family have once again demonstrated their dedication to solving a major national challenge that prevents promising discoveries from advancing to patient benefit."

"The challenge of translating discoveries into clinical development requires an innovative, next-generation business model," said Ron Harrington, a successful entrepreneur and recognized philanthropist. "BioMotiv's mission-aligned model and experienced team will enable it to efficiently and effectively manage a portfolio of early-stage drugs."

BioMotiv is the mission-driven, for-profit therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250 million initiative announced by University Hospitals this past February. "Our mission is 'To Heal. To Teach. To Discover.,'" said Achilles A. Demetriou, MD, PhD, Chief Operating Officer of University Hospitals.  "The project, supported by the generosity of the Harrington family, is a national initiative to advance the standard of care by creating structures that support physician-scientists in developing their insights into new therapies."

The initial capital will be used to launch operations and initiate the development of BioMotiv's technology portfolio which is being sourced from leading academic medical centers and industry sources from across the country.  The company plans to raise a total of $100 million in capital.

About The Harrington Project for Discovery and Development

The Harrington Project for Discovery and Development (The Harrington Project), announced in late February, is a $250 million national initiative to support the discovery and development of breakthrough discoveries by physician-scientists.  The Harrington Project, centered at University Hospitals Case Medical Center, is a new and powerful national model that addresses a set of major challenges in advancing medicine.  It includes the UH Harrington Discovery Institute, a national Innovation Support Center, and BioMotiv. The project, powered by a generous gift and investment from the Harrington family, successful entrepreneurs and recognized philanthropists in Cleveland, provides a comprehensive model to advance discoveries into development and to create novel therapies for patient care.

For more information about The Harrington Project and the UH Harrington Discovery Institute, go to: UHHarringtonDiscoveryInstitute.org.

For more information about BioMotiv, go to: www.BioMotiv.com.


'/>"/>
SOURCE BioMotiv
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMotiv Names New Chief Executive Officer
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Benvenue Medical Secures $25 Million Series D Financing
5. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
6. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
7. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
10. Arthrosurface Hits a $100 Million Milestone
11. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):